Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ATXS
Stock Latest News
Ratings
Promising Developments and Consistent Performance Drive Buy Rating for Astria Therapeutics
7d ago
ATXS
Premium
The Fly
Astria announces initial results from ALPHA-SOLAR target enrollment group
7d ago
ATXS
Premium
Company Announcements
Astria Therapeutics Stockholders Approve Key Amendments
8d ago
8K
ATXS
Premium
Ratings
Astria Therapeutics: Favorable Market Position Amid Competitor Safety Concerns
22d ago
ATXS
Premium
Company Announcements
Astria Therapeutics Reports Increased Loss Amid Rising R&D Costs
1M ago
ATXS
Premium
Ratings
Positive Outlook for Astria Therapeutics: Buy Rating Driven by Promising Clinical Developments and Strategic Focus
1M ago
ATXS
Premium
Ratings
Buy Rating for Astria Therapeutics Driven by Promising Clinical Developments and Strong Financial Position
1M ago
ATXS
Premium
The Fly
Astria Therapeutics price target lowered to $25 from $26 at Citizens JMP
1M ago
ATXS
Premium
The Fly
Astria Therapeutics reports Q1 EPS (58c), consensus (48c)
1M ago
ATXS
Premium
Pre-Earnings
ATXS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ATXS
Premium
Weekend Updates
Chord, InMode, Upstart, BridgeBio, Astria: Trending by Analysts
2M ago
ATXS
BBIO
Premium
The Fly
Astria Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
ATXS
Premium
The Fly
Astria Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
ATXS
Premium
The Fly
Astria Therapeutics price target raised to $28 from $27 at Wedbush
3M ago
ATXS
Premium
Company Announcements
Astria Therapeutics Advances Clinical Trials and Financials
3M ago
ATXS
Premium
Ratings
Astria Therapeutics: Promising Developments and Strategic Advancements Justify Buy Rating
3M ago
ATXS
Premium
Ratings
Astria Therapeutics: Promising Pipeline and Strong Financials Drive Buy Rating
3M ago
ATXS
Premium
Ratings
Buy Rating for Astria Therapeutics: Promising Clinical Advancements and Strong Financial Position
3M ago
ATXS
Premium
Pre-Earnings
Astria Therapeutics, Inc. (ATXS) Q4 Earnings Cheat Sheet
4M ago
ATXS
Premium
Ratings
Promising Trial Results and Growth Potential Justify Buy Rating for Astria Therapeutics
4M ago
ATXS
Premium
The Fly
Astria initiates ALPHA-ORBIT Phase 3 trial of navenibart for HAE treatment
4M ago
ATXS
Premium
The Fly
Zillow initiated, Electronic Arts upgraded: Wall Street’s top analyst calls
5M ago
Z
EA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
